| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
David Henry Mack is President and CEO at PMVP. David Henry Mack's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $623K at current prices.
Historically, David Henry Mack's trades have earned a strong insider score of 73/100 across 6 rated trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +46.5%.
The PMVP filings lean toward selling, a net 100,411 shares.
David Henry Mack has 21 Form 4 filings on record from November 2020 to March 2026, all as President and CEO at PMV Pharmaceuticals (PMVP), 2020–2026.
The 40 reported transactions were 16 option exercises, 8 option or other derivative awards, 6 open-market sales and 6 gifts, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $1.6M.
The largest open-market sale was 27,796 shares of PMVP at an average $35.75 on July 21, 2021, about $994K. Twelve months later PMVP was down 59%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | PMVP Pmv Pharmaceuticals, Inc. | President and CEO | Sell | 58,411 | $1.06 | $62,178.51 | -9.8% | +38.1% | +18.1% | |
| Jul 21, 2021 | PMVP Pmv Pharmaceuticals, Inc. | President and CEO | Sale+OE | 27,796 | $35.75 | $993,651.93 | -69.0% | -33.9% | -58.8% | |
| Jun 28, 2021 | PMVP Pmv Pharmaceuticals, Inc. | President and CEO | Sale+OE | 204 | $35.53 | $7,248.12 | -1.6% | -14.9% | -60.5% | |
| May 21, 2021 | PMVP Pmv Pharmaceuticals, Inc. | President and CEO | Sale+OE | 14,000 | $35.65 | $499,096.38 | -85.0% | -20.3% | -60.3% |